These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15475263)

  • 21. Emergent issues in the genetics of intestinal neoplasia.
    Dove WF; Gould KA; Luongo C; Moser AR; Shoemaker AR
    Cancer Surv; 1995; 25():335-55. PubMed ID: 8718526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
    Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.
    Nnadi SC; Watson R; Innocent J; Gonye GE; Buchberg AM; Siracusa LD
    Carcinogenesis; 2012 Aug; 33(8):1589-97. PubMed ID: 22637734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo.
    Bouxsein ML; Rosen CJ; Turner CH; Ackert CL; Shultz KL; Donahue LR; Churchill G; Adamo ML; Powell DR; Turner RT; Muller R; Beamer WG
    J Bone Miner Res; 2002 Apr; 17(4):570-9. PubMed ID: 11918215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.
    Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A
    Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic effects on bone mechanotransduction in congenic mice harboring bone size and strength quantitative trait loci.
    Robling AG; Warden SJ; Shultz KL; Beamer WG; Turner CH
    J Bone Miner Res; 2007 Jul; 22(7):984-91. PubMed ID: 17371164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
    Baran AA; Silverman KA; Zeskand J; Koratkar R; Palmer A; McCullen K; Curran WJ; Edmonston TB; Siracusa LD; Buchberg AM
    Genome Res; 2007 May; 17(5):566-76. PubMed ID: 17387143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenic mice reveal sex-specific genetic regulation of femoral structure and strength.
    Turner CH; Sun Q; Schriefer J; Pitner N; Price R; Bouxsein ML; Rosen CJ; Donahue LR; Shultz KL; Beamer WG
    Calcif Tissue Int; 2003 Sep; 73(3):297-303. PubMed ID: 14667144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.
    Delahunty KM; Shultz KL; Gronowicz GA; Koczon-Jaremko B; Adamo ML; Horton LG; Lorenzo J; Donahue LR; Ackert-Bicknell C; Kream BE; Beamer WG; Rosen CJ
    Endocrinology; 2006 Aug; 147(8):3915-23. PubMed ID: 16675518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.
    Beckwith J; Cong Y; Sundberg JP; Elson CO; Leiter EH
    Gastroenterology; 2005 Nov; 129(5):1473-84. PubMed ID: 16285949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil.
    Fujimoto K; Fujii G; Mutoh M; Yasunaga M; Tanaka H; Wada M
    Eur J Cancer Prev; 2013 Jan; 22(1):8-10. PubMed ID: 22504657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in
    Godavarthi JD; Polk S; Nunez L; Shivachar A; Glenn Griesinger NL; Matin A
    Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33202710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
    Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
    Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas.
    Cooper HS; Chang WC; Coudry R; Gary MA; Everley L; Spittle CS; Wang H; Litwin S; Clapper ML
    Mol Carcinog; 2005 Sep; 44(1):31-41. PubMed ID: 15937958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model.
    van der Houven van Oordt CW; Smits R; Schouten TG; Houwing-Duistermaat JJ; Williamson SL; Luz A; Meera Khan P; van der Eb AJ; Breuer ML; Fodde R
    Genes Chromosomes Cancer; 1999 Mar; 24(3):191-8. PubMed ID: 10451698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.
    Kwong LN; Shedlovsky A; Biehl BS; Clipson L; Pasch CA; Dove WF
    Genetics; 2007 Jun; 176(2):1237-44. PubMed ID: 17435219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative trait locus on chromosome 18 is a critical determinant of excitotoxic cell death susceptibility.
    Lorenzana A; Chancer Z; Schauwecker PE
    Eur J Neurosci; 2007 Apr; 25(7):1998-2008. PubMed ID: 17439488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.